Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

VCRE

Vicore Pharma Holding AB ADR

13.78

Jul 10 • 04:00PM ET -0.14 (-0.97%)

Healthcare Biotechnology Sweden NASD

Index	-
Market Cap	-
Enterprise Value	-
Income	-
Sales	-
Book/sh	-
Cash/sh	-
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Jul 06, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	-
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	-
Current Ratio	-
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	-
Insider Trans	-
Inst Own	-
Inst Trans	-
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-5.77%
SMA50	-5.77%
SMA200	-5.77%
Trades

Shs Outstand	-
Shs Float	-
Short Float	-
Short Ratio	-
Short Interest	-
52W High	17.80 -22.58%
52W Low	13.17 4.63%
Volatility	- -
ATR (14)	2.01
RSI (14)	-
Beta	-
Rel Volume	0.12
Avg Volume	203.10K
Volume	23,497

Perf Week	-
Perf Month	-
Perf Quarter	-
Perf Half Y	-
Perf YTD	-7.52%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	13.91
Price	13.78
Change	-0.97%

Jul-07-26 02:20AM

Vicore Pharma to Participate in the Leerink Therapeutics Forum

(ACCESSWIRE) -7.54%

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VCRE

Vicore Pharma Holding AB ADR

Upgrade your Finviz experience